Open Up a World Beyond Their Asthma Symptoms

For results they can feel, prescribe DUPIXENT to target type 2 inflammation, treat OCS-dependent and type 2 asthma patients, and transform their lives with rapid, sustained control... Choose DUPIXENT to open up a world beyond their asthma symptoms.

1. IL-4 and IL-13, two key and central drivers of type 2 inflammation
2. TREAT OCS-dependent patients3 & Type 2 asthma patients
3. TRANSFORM patient lives beyond symptoms

• 86% of patients reduced or eliminated OCS while maintaining asthma control3,a
• Up to 550 mL improvement in FEV16,b
• Up to 75% exacerbation reduction6,c